AstraZeneca Vaxzevria COVID-19 Vaccine from Japan
Vaxzevria is a COVID-19 vaccine using a chimpanzee adenovirus vector to express the SARS-CoV-2 spike protein, triggering an immune response. It is supplied in multi-dose vials for retail distribution, qualifying as an immunological product under tariff item 3002.15.00.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the vaccine is accompanied by a valid Health Canada import authorization under the Food and Drugs Act
• Declare the product as an immunological product in measured doses for retail sale, and keep records of the lot numbers and cold-chain documentation for CBSA inspection